TIAA CREF Investment Management LLC acquired a new position in Sientra Inc (NASDAQ:SIEN) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 38,305 shares of the medical instruments supplier’s stock, valued at approximately $372,000. TIAA CREF Investment Management LLC owned 0.20% of Sientra at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently modified their holdings of the business. JPMorgan Chase & Co. purchased a new position in shares of Sientra during the second quarter valued at approximately $101,000. Wells Fargo & Company MN increased its position in shares of Sientra by 0.3% during the first quarter. Wells Fargo & Company MN now owns 12,871 shares of the medical instruments supplier’s stock valued at $108,000 after acquiring an additional 40 shares in the last quarter. Accredited Investors Inc. bought a new stake in shares of Sientra during the second quarter valued at approximately $115,000. Parametric Portfolio Associates LLC increased its position in shares of Sientra by 14.4% during the first quarter. Parametric Portfolio Associates LLC now owns 16,410 shares of the medical instruments supplier’s stock valued at $138,000 after acquiring an additional 2,065 shares in the last quarter. Finally, KCG Holdings Inc. bought a new stake in shares of Sientra during the first quarter valued at approximately $147,000. Institutional investors and hedge funds own 76.63% of the company’s stock.
Shares of Sientra Inc (NASDAQ:SIEN) traded up $0.03 during mid-day trading on Thursday, reaching $12.97. 119,911 shares of the company’s stock traded hands, compared to its average volume of 152,400. Sientra Inc has a 1-year low of $7.20 and a 1-year high of $16.68. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.92 and a current ratio of 2.87.
Sientra (NASDAQ:SIEN) last posted its earnings results on Tuesday, November 7th. The medical instruments supplier reported ($0.74) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.68) by ($0.06). Sientra had a negative return on equity of 68.82% and a negative net margin of 169.77%. The business had revenue of $9.80 million during the quarter, compared to the consensus estimate of $10.54 million. During the same quarter last year, the firm earned ($0.55) earnings per share. The business’s quarterly revenue was up 50.8% on a year-over-year basis. equities analysts expect that Sientra Inc will post -3.14 earnings per share for the current fiscal year.
SIEN has been the subject of several analyst reports. Canaccord Genuity began coverage on shares of Sientra in a research report on Monday, August 28th. They set a “buy” rating and a $14.00 price target for the company. Stifel Nicolaus reaffirmed a “hold” rating and issued a $14.00 target price (up previously from $11.00) on shares of Sientra in a research report on Wednesday, September 27th. William Blair upgraded shares of Sientra from a “market perform” rating to an “outperform” rating in a research note on Wednesday, September 13th. BidaskClub cut shares of Sientra from a “hold” rating to a “sell” rating in a research note on Thursday. Finally, Zacks Investment Research cut shares of Sientra from a “hold” rating to a “sell” rating in a research note on Tuesday, August 15th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $13.75.
WARNING: “TIAA CREF Investment Management LLC Buys Shares of 38,305 Sientra Inc (NASDAQ:SIEN)” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2017/12/07/tiaa-cref-investment-management-llc-buys-shares-of-38305-sientra-inc-sien.html.
Sientra Company Profile
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Receive News & Ratings for Sientra Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra Inc and related companies with MarketBeat.com's FREE daily email newsletter.